Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled study

OBJECTIVES: Chronic constipation (CC), a common functional gastrointestinal disorder, has laxatives as its mainstay of treatment. Refractoriness to laxatives calls for better treatment options. Prucalopride is a novel, well-tolerated enterokinetic with high 5-hydroxytryptamine 4 receptor selectivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehury, Suhasini, Mohapatra, Sourya, Das, Haribhakti Seba, Goutam, Siddhartha, Kaushik, Chetna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204899/
https://www.ncbi.nlm.nih.gov/pubmed/36960515
http://dx.doi.org/10.4103/ijp.ijp_530_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204899/
https://www.ncbi.nlm.nih.gov/pubmed/36960515
http://dx.doi.org/10.4103/ijp.ijp_530_22

Ejemplares similares